Intensity Therapeutics Inc (INTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,590 | 8,556 | 1,312 | 4,539 | 9,316 |
| Marketable Securities | 0 | 6,220 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 76 | 191 | 162 |
| TOTAL | $3,363 | $15,464 | $1,451 | $4,730 | $9,478 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,420 | 1,831 | 306 | 486 | 672 |
| TOTAL | $1,420 | $1,831 | $306 | $486 | $672 |
| Total Assets | $4,783 | $17,295 | $1,757 | $5,216 | $10,150 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,219 | 3,048 | 603 | 173 | 223 |
| Accrued Expenses | 508 | 891 | 1,724 | 1,349 | 952 |
| TOTAL | $1,755 | $3,959 | $6,819 | $3,721 | $1,346 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 36 | 36 | 36 | 36 |
| TOTAL | $110 | $174 | $36 | $180 | $362 |
| Total Liabilities | $1,865 | $4,133 | $6,855 | $3,900 | $1,708 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,181 | 13,709 | N/A | N/A | N/A |
| Common Shares | 2 | 1 | N/A | 1 | 1 |
| Retained earnings | -66,783 | -50,515 | -38,653 | -31,071 | -23,176 |
| Other shareholders' equity | 0 | 0 | 10,000 | 10,000 | 9,950 |
| TOTAL | $2,918 | $13,162 | $-5,098 | $1,316 | $8,442 |
| Total Liabilities And Equity | $4,783 | $17,295 | $1,757 | $5,216 | $10,150 |